Autoimmune hair loss: how is the connection established?

Autoimmunity does not explain every type of hair loss

The immune system normally protects the body against threats such as infection. In an autoimmune condition, an abnormal response targets parts of the body itself. This does not mean that all immune defences are too strong, or that they necessarily attack hair: the tissue involved depends on the particular disorder.

This distinction helps avoid confusing alopecia with autoimmune disease. Alopecia describes loss of scalp or body hair and has several possible causes. Shedding after a fever, breakage from styling practices and an immune process affecting a follicle do not share the same underlying mechanism.

Association also needs to be distinguished from causation. Some autoimmune conditions occur together more often, without one automatically explaining every symptom of the other. A family history or another autoimmune diagnosis is useful information for the clinician, but it cannot establish that a new episode of shedding is immune-driven.

When immune activity directly affects the follicle

Alopecia areata is an example of direct involvement. Immune activity interrupts hair production and can cause fairly sudden patches of loss, often on skin without obvious scarring. Eyebrows, eyelashes and other areas of body hair may also be affected, while some forms produce more widespread thinning.

Regrowth remains possible in this condition, although its course varies. NIAMS notes that many affected people are otherwise healthy and have no additional symptoms. A patch of alopecia areata therefore does not automatically mean that a serious disease affecting other organs is developing.

Other inflammatory disorders, such as lichen planopilaris, can damage the structures that allow follicles to renew themselves. These belong to the scarring alopecias: once a follicle has been destroyed, it cannot resume producing hair. Their mechanisms remain complex, and all scarring conditions should not be treated as one single autoimmune disease.

A round shape, smooth skin or some itching cannot settle the diagnosis. Broken hairs, a scalp infection or repeated tension on hair can also create areas with reduced coverage. Examination looks for a consistent set of findings rather than one visual clue assumed to provide the whole answer.

When a condition affects hair indirectly

Hashimoto’s thyroiditis illustrates a different situation. The immune response involves the thyroid and can reduce its hormone production; that change in function can then contribute to dry or thinning hair. Describing every associated shedding episode as a direct immune attack on the hair roots would be inaccurate.

NIDDK explains that someone with Hashimoto’s disease may initially have no symptoms and may not need hormone treatment if thyroid function remains adequate. The relationship between thyroid function and hair loss therefore needs an examination and appropriate blood tests. The presence of thyroid antibodies alone does not determine a hair treatment plan.

Lupus-related hair changes show another combination of processes. Some skin lesions directly involve the scalp, while diffuse shedding may accompany disease activity or a change in the hair cycle. Concha and Werth’s review also distinguishes hair loss occurring in someone with lupus that is not specific to lupus itself.

An illness that strains the body, inadequate food intake or certain medicines may contribute to shedding. These possibilities guide questions rather than justify diagnosing yourself with a deficiency or an adverse drug reaction. The clinician needs to establish what is actually present and which explanations remain unconfirmed.

A known diagnosis does not explain every new episode

When you already have an autoimmune diagnosis, it can be tempting to attribute every hair change to it. However, androgenetic alopecia may develop alongside it, as can telogen effluvium after fever or weight loss. Treatment of the original condition may therefore be appropriate without resolving every part of the reduction in hair volume.

Timing helps separate these possibilities. Shedding that starts weeks or months after an event may have a different explanation from a patch appearing with local inflammation. Improvement in symptoms elsewhere in the body does not always produce an immediate visible change in the hair.

Give the prescriber a list of medicines and supplements, including when they were started or changed. Do not withdraw a prescription to test whether it is causing the shedding. A flare and a treatment adjustment can happen together; reviewing the clinical history helps assess that relationship without jeopardising control of the underlying condition.

What to note before your appointment

Begin with a straightforward description of the change: increased shedding, a thinner area, several patches or strands that break. Explain when you first noticed it and whether other areas, such as your eyebrows, have changed. An older photograph can help illustrate this history, without serving as a diagnostic test.

Mention accompanying symptoms even if you are unsure whether they are connected: unusual tiredness, weight changes, feeling cold, skin lesions or joint pain. There are many possible explanations for these symptoms. Their combination and progression help the clinician select investigations rather than confirm an autoimmune diagnosis in advance.

Rapid spread, persistent pain, crusting, pustules or inflammation around hairs are reasons to contact your GP rather than wait for a cosmetic consultation. Some scarring disorders progress with little discomfort, so absence of pain does not remove the need for assessment. Your GP can arrange referral to a dermatologist when appropriate.

Bring existing clinical reports and describe treatments or products already tried. The professional managing your general condition and the dermatologist may need to share their findings. A practical aim for the first appointment is to understand the leading explanation, what still needs checking and when the situation should be reviewed.

Investigations should answer a specific question

The dermatologist examines the hair and skin, sometimes including the nails and other areas according to your symptoms. Magnification during trichoscopy allows closer assessment of follicular openings, hair shafts and possible inflammatory changes. A photograph taken at home cannot provide all this information, even when it appears clear.

With typical alopecia areata, examination may provide sufficient diagnostic information, while tests or a biopsy address additional uncertainty. If a scarring condition is suspected, a skin sample becomes more important. Cummins and colleagues (2021) emphasise selecting the sampling site carefully and interpreting clinical observations together with the laboratory findings.

Blood tests have different purposes. Thyroid tests assess hormone function, antibody tests address a particular suspicion, and other investigations may explore anaemia or a deficiency suggested by the clinical circumstances. There is no single autoimmune hair panel that can identify every possible explanation for shedding.

A result must be considered alongside the reason the test was requested. Reassuring blood results do not, on their own, explain a persistent scalp patch, and an abnormal value does not automatically prove it caused the hair loss. This interpretation helps avoid treating a number while overlooking the appearance and changing condition of the scalp.

Treatments cannot simply be transferred between conditions

Treatment is chosen for the process identified and its impact on your life. For some people with alopecia areata, monitoring agreed with the clinician is an option; others are offered local treatment or specialist medicines. NIAMS notes that age, the extent of involvement and personal preferences all matter to that decision.

Corticosteroids applied to the skin or injected into selected patches are used for specific dermatological indications. Medicines acting more broadly or targeting immune pathways require specialist assessment and monitoring. They are not a shared solution for every type of shedding in someone with an autoimmune condition.

By contrast, confirmed thyroid hormone deficiency calls for treatment of that hormonal problem, rather than an application intended to suppress scalp inflammation. Active scarring disease requires another approach again. Following a prescription given to someone with a different condition may therefore miss the problem that needs addressing.

Minoxidil and hair-growth products cannot identify the cause of shedding or replace treatment of an underlying disease. Any role they might have depends on the diagnosis. A shampoo, oil or supplement cannot rebuild the structures of a follicle that has been destroyed by scarring.

Follow-up involves more than looking for regrowth

The goal may be improved coverage, but it can also be preventing an affected area from spreading or relieving scalp discomfort. These outcomes do not necessarily develop at the same pace. In scarring disease, retaining functioning follicles may be a meaningful benefit even if an older bare patch remains visible.

Where regrowth is possible, its timing and durability still vary. Alopecia areata can recur, while shedding linked to another disorder may require reassessment of contributing factors. Ask your clinician which changes to watch for and when to return sooner, rather than judging progress each day by the number of hairs found.

Bare areas may need protection from sunlight or cold. A comfortable hairstyle, headscarf or wig may help if you want one, with attention to friction and skin tolerance. These cosmetic choices can accompany treatment without changing the activity of the underlying condition.

Avoid combining products that claim to boost immunity or nourish the hair without establishing their value in your circumstances. NIDDK specifically warns that excessive iodine can be problematic in autoimmune thyroid disease. Discuss supplements with your doctor or pharmacist instead of assuming that a product described as natural must be suitable.

Your experience also matters: hair loss can affect relationships, activities or how you feel about your appearance. Psychological support is an option even when the examination suggests recovery may be possible. Feeling worried cannot, on its own, explain the shedding or replace an assessment of its cause.

Transplant decisions depend on the hair-loss diagnosis

A transplant redistributes your own follicles. Simply describing grafts as foreign bodies being rejected would therefore be misleading: a relevant question is whether disease can continue to affect the hair and recipient skin. The name of an autoimmune condition alone cannot establish either suitability for surgery or a reason to rule out every procedure.

The NHS states that transplantation is not usually suitable for alopecia areata. Potentially reversible widespread shedding needs its cause addressed first, and active inflammation requires medical care. Our guide to the stages of hair transplantation does not replace this assessment of whether surgery has a role.

If a different cause of lasting hair loss is confirmed, a proposal may be considered in light of general health, medicines and the available donor hair. No standard symptom-free interval is sufficient proof of suitability. The decision should explain uncertainties and the reasons for continuing medical care, postponing surgery or deciding against it.

When discussing a hair transplant in Istanbul with Body Expert, existing medical conclusions help place your enquiry in context. The process starts with a clarified cause of hair loss, without turning suspected autoimmunity into a reason to operate. Appropriate support may also lead to a solution without surgery.

Sources

National Institute of Arthritis and Musculoskeletal and Skin Diseases. (2024, August). Alopecia areata: Overview, symptoms, and causes. Public health information.

National Institute of Arthritis and Musculoskeletal and Skin Diseases. (2024, August). Alopecia areata: Diagnosis, treatment, and steps to take. Public health information.

National Institute of Diabetes and Digestive and Kidney Diseases. (2021, June). Hashimoto’s disease. Public health information.

Concha, J. S. S., & Werth, V. P. (2018). Alopecias in lupus erythematosus. Lupus Science & Medicine, 5(1), e000291. Full text.

Cummins, D. M., Chaudhry, I. H., & Harries, M. (2021). Scarring alopecias: Pathology and an update on digital developments. Biomedicines, 9(12), 1755. Full text.

National Health Service. (2023, September 29). Hair transplant. Public health information, accessed 17 October 2026.